{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:36:49Z","timestamp":1787798209336,"version":"build-2784847793"},"reference-count":58,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00004","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T22:33:54Z","timestamp":1485470034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes"],"prefix":"10.3389","volume":"8","author":[{"given":"Massimo","family":"Mangiola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Marrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Feingold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"issue":"4","key":"B2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/MOT.0b013e3283636c71","article-title":"Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation","volume":"18","author":"Campbell","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"issue":"7","key":"B3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s12265-014-9587-z","article-title":"Human leukocyte antigens and alloimmunization in heart transplantation: an open debate","volume":"7","author":"Picascia","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"issue":"5","key":"B4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/MOT.0b013e328364fe3d","article-title":"The detection and role of circulating antibodies in rejection","volume":"18","author":"Eckels","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"B5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.healun.2015.10.013","article-title":"Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens","volume":"35","author":"Reinsmoen","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"22","key":"B6","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1161\/CIRCULATIONAHA.113.001378","article-title":"Transplantation in the highly sensitized pediatric patient","volume":"129","author":"Castleberry","year":"2014","journal-title":"Circulation"},{"issue":"9","key":"B7","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and Titer Information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant"},{"issue":"8","key":"B8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.humimm.2016.05.025","article-title":"Can solid phase assays be better utilized to measure efficacy of antibody removal therapies?","volume":"77","author":"Tambur","year":"2016","journal-title":"Hum Immunol"},{"issue":"3","key":"B9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/cei.12127","article-title":"The significance of pretransplant donor-specific antibodies reactive with intact or denatured human leucocyte antigen in kidney transplantation","volume":"173","author":"Otten","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"B10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.healun.2012.09.023","article-title":"Outcomes after listing with a requirement for a prospective crossmatch in pediatric heart transplantation","volume":"32","author":"Feingold","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"519680","DOI":"10.1155\/2013\/519680","article-title":"Occurrence of fatal and nonfatal adverse outcomes after heart transplantation in patients with pretransplant noncytotoxic HLA antibodies","volume":"2013","author":"Potena","year":"2013","journal-title":"J Transplant"},{"issue":"9","key":"B12","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/ctr.12590","article-title":"Changes in the methodology of pre-heart transplant human leukocyte antibody assessment: an analysis of the United Network for Organ Sharing database","volume":"29","author":"O\u2019Connor","year":"2015","journal-title":"Clin Transplant"},{"issue":"11","key":"B13","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/tri.12170","article-title":"Donor-specific anti-HLA antibodies detected by Luminex: predictive for short-term but not long-term survival after heart transplantation","volume":"26","author":"Raess","year":"2013","journal-title":"Transpl Int"},{"issue":"2","key":"B14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"issue":"6","key":"B15","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/TP.0b013e318244f7b8","article-title":"Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody","volume":"93","author":"Hodges","year":"2012","journal-title":"Transplantation"},{"issue":"1","key":"B16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.humimm.2010.10.013","article-title":"Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival","volume":"72","author":"Ho","year":"2011","journal-title":"Hum Immunol"},{"issue":"3","key":"B17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"B18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/MOT.0b013e3283577fef","article-title":"Antibody-mediated rejection","volume":"17","author":"Kittleson","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"issue":"10","key":"B19","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1016\/j.transproceed.2011.08.077","article-title":"Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes","volume":"43","author":"Gandhi","year":"2011","journal-title":"Transplant Proc"},{"issue":"1","key":"B20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Zeevi","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"B21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/tri.12684","article-title":"Novel insights into pretransplant allosensitization in heart transplant recipients in the contemporary era of immunosuppression and rejection surveillance","volume":"29","author":"Svobodova","year":"2016","journal-title":"Transpl Int"},{"issue":"8","key":"B22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.healun.2013.05.012","article-title":"Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation","volume":"32","author":"Tible","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"B23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/ajcp\/aqv016","article-title":"Correlation of circulating complement-fixing donor-specific antibodies identified by the C1q assay and presence of C4d in endomyocardial biopsy specimens","volume":"145","author":"Frank","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"B24","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.healun.2015.03.002","article-title":"Late antibody-mediated rejection after heart transplantation: mortality, graft function, and fulminant cardiac allograft vasculopathy","volume":"34","author":"Coutance","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"B25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/ajt.13529","article-title":"Late failing heart allografts: pathology of cardiac allograft vasculopathy and association with antibody-mediated rejection","volume":"16","author":"Loupy","year":"2016","journal-title":"Am J Transplant"},{"issue":"9","key":"B26","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.healun.2016.04.007","article-title":"The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection","volume":"35","author":"Clerkin","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"B27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/TP.0b013e318273878c","article-title":"Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study","volume":"95","author":"Topilsky","year":"2013","journal-title":"Transplantation"},{"issue":"6","key":"B28","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1309\/AJCPTLBEU5BQ8SHN","article-title":"Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy","volume":"142","author":"Frank","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"B29","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1600-6143.2011.03563.x","article-title":"Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy","volume":"11","author":"Loupy","year":"2011","journal-title":"Am J Transplant"},{"issue":"6","key":"B30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.healun.2007.03.015","article-title":"Survival in allosensitized children after listing for cardiac transplantation","volume":"26","author":"Feingold","year":"2007","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"B31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jtcvs.2010.04.009","article-title":"Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database","volume":"140","author":"Rossano","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"B32","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.healun.2011.06.005","article-title":"Allosensitization and outcomes in pediatric heart transplantation","volume":"30","author":"Mahle","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"B33","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.healun.2012.08.006","article-title":"Listing requirements for a prospective crossmatch in pediatric heart transplantation: analysis of Organ Procurement and Transplantation Network data from 1996 to 2009","volume":"31","author":"Feingold","year":"2012","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"B34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00246-011-9928-5","article-title":"Outcomes of cardiac transplantation in highly sensitized pediatric patients","volume":"32","author":"Scott","year":"2011","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"B35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.healun.2014.09.027","article-title":"Outcomes in highly sensitized pediatric heart transplant patients using current management strategies","volume":"34","author":"Asante-Korang","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"B36","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1111\/ajt.13259","article-title":"Development and impact of de novo anti-HLA antibodies in pediatric heart transplant recipients","volume":"15","author":"Chen","year":"2015","journal-title":"Am J Transplant"},{"issue":"1","key":"B37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.healun.2015.08.008","article-title":"Donor-specific HLA alloantibodies: impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation","volume":"35","author":"Tran","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"B38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1399-3046.2010.01446.x","article-title":"Donor-specific HLA antibodies in paediatric cardiac transplant recipients are associated with poor graft survival","volume":"15","author":"Irving","year":"2011","journal-title":"Pediatr Transplant"},{"issue":"8","key":"B39","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/petr.12606","article-title":"Risk factors for the development of donor-specific antibodies after pediatric heart transplantation","volume":"19","author":"Godown","year":"2015","journal-title":"Pediatr Transplant"},{"issue":"12","key":"B40","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.healun.2016.06.014","article-title":"A multi-institutional evaluation of antibody-mediated rejection utilizing the Pediatric Heart Transplant Study database: incidence, therapies and outcomes","volume":"35","author":"Thrush","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"B41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.humimm.2009.06.015","article-title":"Alloantibodies in heart transplantation","volume":"70","author":"Ho","year":"2009","journal-title":"Hum Immunol"},{"issue":"2","key":"B42","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients","volume":"30","author":"Chin","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"B43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.healun.2015.10.006","article-title":"The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children","volume":"35","author":"Ware","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"B44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/petr.12075","article-title":"Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?","volume":"17","author":"Peng","year":"2013","journal-title":"Pediatr Transplant"},{"issue":"13","key":"B45","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"B46","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1399-3046.2012.01690.x","article-title":"Cardiac antibody-mediated rejection","volume":"16","author":"Chin","year":"2012","journal-title":"Pediatr Transplant"},{"issue":"10","key":"B47","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.healun.2015.05.001","article-title":"Effect of persistent versus transient donor-specific HLA antibodies on graft outcomes in pediatric cardiac transplantation","volume":"34","author":"Irving","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"B48","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":"Reduction of alloantibodies via proteasome inhibition in cardiac transplantation","volume":"30","author":"Patel","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"B49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11936-015-0431-9","article-title":"Desensitization strategies pre- and post-cardiac transplantation","volume":"18","author":"Cole","year":"2016","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"6","key":"B50","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.healun.2011.02.002","article-title":"Current and future challenges in therapy for antibody-mediated rejection","volume":"30","author":"Nair","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"B51","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.healun.2015.01.982","article-title":"Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation","volume":"34","author":"Khuu","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"B52","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.healun.2016.03.021","article-title":"Desensitization strategies in adult heart transplantation-Will persistence pay off?","volume":"35","author":"Chih","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"B53","doi-asserted-by":"publisher","first-page":"E61","DOI":"10.1111\/j.1399-0012.2010.01334.x","article-title":"The long-term outcome of treated sensitized patients who undergo heart transplantation","volume":"25","author":"Kobashigawa","year":"2011","journal-title":"Clin Transplant"},{"issue":"8","key":"B54","doi-asserted-by":"publisher","first-page":"E280","DOI":"10.1111\/petr.12347","article-title":"HLA desensitization with bortezomib in a highly sensitized pediatric patient","volume":"18","author":"May","year":"2014","journal-title":"Pediatr Transplant"},{"issue":"4","key":"B55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jca.21270","article-title":"Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection","volume":"28","author":"Jackups","year":"2013","journal-title":"J Clin Apher"},{"issue":"3","key":"B56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/TP.0b013e31823f7eea","article-title":"Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients","volume":"93","author":"Morrow","year":"2012","journal-title":"Transplantation"},{"issue":"1","key":"B57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ppedcard.2011.06.009","article-title":"Immune monitoring of pediatric heart transplant recipients through serial donor specific antibody testing \u2013 an initial experience and review of the literature","volume":"32","author":"Gambetta","year":"2011","journal-title":"Prog Pediatr Cardiol"},{"issue":"7","key":"B58","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/petr.12131","article-title":"Antibody depletion for the treatment of crossmatch-positive pediatric heart transplant recipients","volume":"17","author":"Daly","year":"2013","journal-title":"Pediatr Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00004\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T22:33:55Z","timestamp":1485470035000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00004\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":58,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00004","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]}}}